• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种人类抗体与α-半乳糖受体结合,并模拟艰难梭菌毒素A对大鼠结肠的作用。

A human antibody binds to alpha-galactose receptors and mimics the effects of Clostridium difficile toxin A in rat colon.

作者信息

Pothoulakis C, Galili U, Castagliuolo I, Kelly C P, Nikulasson S, Dudeja P K, Brasitus T A, LaMont J T

机构信息

Section of Gastroenterology, Evans Memorial Department of Clinical Research, Boston University School of Medicine, Massachusetts, USA.

出版信息

Gastroenterology. 1996 Jun;110(6):1704-12. doi: 10.1053/gast.1996.v110.pm8964394.

DOI:10.1053/gast.1996.v110.pm8964394
PMID:8964394
Abstract

BACKGROUND & AIMS: Nearly all human sera contain an immunoglobulin G antibody (antigalactose) that binds the trisaccharide Gal alpha 1-3Gal beta 1-4GlcNAc expressed on cells from most mammals but not humans. Because the Clostridium difficile toxin A receptor in rodents contains this trisaccharide, the aim of this study was to examine whether antigalactose could mimic the enterotoxic effects of toxin A and bind to receptors containing this trisaccharide.

METHODS

Fluid secretion, [3H]-mannitol permeability, and release of rat mast cell protease II and prostaglandin E2 were measured after luminal exposure of rat colon to either purified human anti-galactose, control immunoglobulin G, toxin A, or buffer.

RESULTS

Toxin A (5 micrograms) and antigalactose (250 micrograms) but not control immunoglobulin (250 micrograms) stimulated colonic fluid secretion and caused increased mannitol permeability and rat mast cell protease II release. Antigalactose and toxin A and, to a lesser degree, control immunoglobulin G also stimulated release of prostaglandin E2, but only toxin A produced acute inflammation of rat colonic mucosa. Antigalactose and toxin A bound specifically to a single class of colonic brush border receptors with dissociation constants of 10(-6) mol/L and 5.4 x 10(-8) mol/L, respectively.

CONCLUSIONS

Fluid secretion, increased permeability, and mast cell activation occur in rat colon when toxin A or human antigalactose immunoglobulin G bind to receptors bearing the trisaccharide Gal alpha 1-3Gal beta 1-4GlcNAc.

摘要

背景与目的

几乎所有人类血清都含有一种免疫球蛋白G抗体(抗半乳糖抗体),该抗体能结合大多数哺乳动物细胞(而非人类细胞)上表达的三糖Galα1-3Galβ1-4GlcNAc。由于啮齿动物体内艰难梭菌毒素A的受体含有这种三糖,本研究旨在探究抗半乳糖抗体是否能模拟毒素A的肠毒素作用并与含有该三糖的受体结合。

方法

将大鼠结肠腔内暴露于纯化的人抗半乳糖抗体、对照免疫球蛋白G、毒素A或缓冲液后,测量液体分泌、[3H]-甘露醇通透性以及大鼠肥大细胞蛋白酶II和前列腺素E2的释放。

结果

毒素A(5微克)和抗半乳糖抗体(250微克)而非对照免疫球蛋白(250微克)刺激结肠液体分泌,导致甘露醇通透性增加和大鼠肥大细胞蛋白酶II释放。抗半乳糖抗体和毒素A,以及程度较轻的对照免疫球蛋白G也刺激前列腺素E2的释放,但只有毒素A会引起大鼠结肠黏膜急性炎症。抗半乳糖抗体和毒素A特异性结合到一类结肠刷状缘受体上,解离常数分别为10^(-6)摩尔/升和5.4×10^(-8)摩尔/升。

结论

当毒素A或人抗半乳糖免疫球蛋白G与带有三糖Galα1-3Galβ1-4GlcNAc的受体结合时,大鼠结肠会出现液体分泌增加、通透性增加和肥大细胞活化。

相似文献

1
A human antibody binds to alpha-galactose receptors and mimics the effects of Clostridium difficile toxin A in rat colon.一种人类抗体与α-半乳糖受体结合,并模拟艰难梭菌毒素A对大鼠结肠的作用。
Gastroenterology. 1996 Jun;110(6):1704-12. doi: 10.1053/gast.1996.v110.pm8964394.
2
Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.布拉氏酵母菌蛋白酶可抑制艰难梭菌毒素A和B对人结肠黏膜的作用。
Infect Immun. 1999 Jan;67(1):302-7. doi: 10.1128/IAI.67.1.302-307.1999.
3
A receptor decoy inhibits the enterotoxic effects of Clostridium difficile toxin A in rat ileum.一种受体诱饵可抑制艰难梭菌毒素A对大鼠回肠的肠毒性作用。
Gastroenterology. 1996 Aug;111(2):433-8. doi: 10.1053/gast.1996.v111.pm8690209.
4
Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding.含有针对艰难梭菌毒素A的免疫球蛋白A抗体的人结肠抽吸物可抑制毒素A与受体的结合。
Gastroenterology. 1992 Jan;102(1):35-40. doi: 10.1016/0016-5085(92)91781-x.
5
Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc.艰难梭菌肠毒素的细胞表面结合位点:含序列Galα1-3Galβ1-4GlcNAc的糖缀合物的证据
Infect Immun. 1986 Sep;53(3):573-81. doi: 10.1128/iai.53.3.573-581.1986.
6
Ketotifen inhibits Clostridium difficile toxin A-induced enteritis in rat ileum.酮替芬可抑制艰难梭菌毒素A诱导的大鼠回肠炎。
Gastroenterology. 1993 Sep;105(3):701-7. doi: 10.1016/0016-5085(93)90886-h.
7
Nitric oxide inhibits rat intestinal secretion by Clostridium difficile toxin A but not Vibrio cholerae enterotoxin.一氧化氮可抑制艰难梭菌毒素A引起的大鼠肠道分泌,但对霍乱弧菌肠毒素无此作用。
Gastroenterology. 1996 Aug;111(2):409-18. doi: 10.1053/gast.1996.v111.pm8690206.
8
Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum.神经元在艰难梭菌毒素A和霍乱弧菌肠毒素对大鼠回肠肠道作用中的参与情况。
Gastroenterology. 1994 Sep;107(3):657-65. doi: 10.1016/0016-5085(94)90112-0.
9
Characterization of rabbit ileal receptors for Clostridium difficile toxin A. Evidence for a receptor-coupled G protein.艰难梭菌毒素A兔回肠受体的特性。受体偶联G蛋白的证据。
J Clin Invest. 1991 Jul;88(1):119-25. doi: 10.1172/JCI115267.
10
Molecular mimicry in the recognition of glycosphingolipids by Gal alpha 3 Gal beta 4 GlcNAc beta-binding Clostridium difficile toxin A, human natural anti alpha-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor.由Galα3Galβ4GlcNAcβ结合的艰难梭菌毒素A、人类天然抗α-半乳糖基IgG和单克隆抗体Gal-13识别糖鞘脂中的分子模拟:一种与动物受体不同的具有结合活性的人类糖鞘脂的特性
Glycobiology. 1996 Sep;6(6):599-609. doi: 10.1093/glycob/6.6.599.

引用本文的文献

1
Non-Digestible Oligosaccharides and Short Chain Fatty Acids as Therapeutic Targets against Enterotoxin-Producing Bacteria and Their Toxins.不可消化寡糖和短链脂肪酸作为针对产肠毒素细菌及其毒素的治疗靶点
Toxins (Basel). 2021 Feb 25;13(3):175. doi: 10.3390/toxins13030175.
2
Human intestinal enteroids as a model of -induced enteritis.人肠类器官作为 - 诱导性肠炎模型。
Am J Physiol Gastrointest Liver Physiol. 2020 May 1;318(5):G870-G888. doi: 10.1152/ajpgi.00045.2020. Epub 2020 Mar 30.
3
Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects.
艰难梭菌毒素A和B:对致病特性及肠外效应的见解
Toxins (Basel). 2016 May 3;8(5):134. doi: 10.3390/toxins8050134.
4
Human Clostridium difficile infection: altered mucus production and composition.人类艰难梭菌感染:黏液产生和组成的改变
Am J Physiol Gastrointest Liver Physiol. 2015 Mar 15;308(6):G510-24. doi: 10.1152/ajpgi.00091.2014. Epub 2014 Dec 31.
5
Clostridium difficile infection: molecular pathogenesis and novel therapeutics.艰难梭菌感染:分子发病机制与新型治疗方法。
Expert Rev Anti Infect Ther. 2014 Jan;12(1):131-50. doi: 10.1586/14787210.2014.866515.
6
In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B.体内生理和转录谱分析揭示了宿主对艰难梭菌毒素 A 和毒素 B 的反应。
Infect Immun. 2013 Oct;81(10):3814-24. doi: 10.1128/IAI.00869-13. Epub 2013 Jul 29.
7
Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A.艰难梭菌毒素A受体结合C末端重复序列的晶体结构
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18373-8. doi: 10.1073/pnas.0506391102. Epub 2005 Dec 12.
8
Studying the interaction of alpha-gal carbohydrate antigen and proteins by quartz-crystal microbalance.通过石英晶体微天平研究α-半乳糖碳水化合物抗原与蛋白质的相互作用。
J Am Chem Soc. 2003 Aug 6;125(31):9292-3. doi: 10.1021/ja035350a.
9
Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.布拉氏酵母菌蛋白酶可抑制艰难梭菌毒素A和B对人结肠黏膜的作用。
Infect Immun. 1999 Jan;67(1):302-7. doi: 10.1128/IAI.67.1.302-307.1999.